The sources describe how the T4-AVV platform helps to overcome five significant barriers to gene therapy delivery by enabling the delivery of multiple copies of large DNA molecules, providing efficient endosomal escape, displaying targeting ligands on the capsid surface, increasing the copy number of functional proteins, and enabling the packaging of proteins into the capsid.
Full Article: https://www.nature.com/articles/s41467-023-38364-1